Literature DB >> 24426717

A targeted approach to a giant gastrointestinal stromal tumor of the esophagus.

Arvind Krishnamurthy1.   

Abstract

Entities:  

Year:  2013        PMID： 24426717      PMCID： PMC3693140          DOI： 10.1007/s13193-013-0224-0

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


× No keyword cloud information.
  5 in total

Review 1.  Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

2.  Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665.

Authors:  Burton L Eisenberg; Jonathan Harris; Charles D Blanke; George D Demetri; Michael C Heinrich; James C Watson; John P Hoffman; Scott Okuno; John M Kane; Margaret von Mehren
Journal:  J Surg Oncol       Date:  2009-01-01       Impact factor: 3.454

3.  Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).

Authors:  M Fiore; E Palassini; E Fumagalli; S Pilotti; E Tamborini; S Stacchiotti; E Pennacchioli; P G Casali; A Gronchi
Journal:  Eur J Surg Oncol       Date:  2008-12-24       Impact factor: 4.424

4.  Esophageal gastrointestinal stromal tumor: report of 7 patients.

Authors:  A B Shinagare; K A Zukotynski; K M Krajewski; J P Jagannathan; J Butrynski; J L Hornick; N H Ramaiya
Journal:  Cancer Imaging       Date:  2012-04-27       Impact factor: 3.909

5.  The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction.

Authors:  Wilko I Staiger; Ulrich Ronellenfitsch; Georg Kaehler; Hans Ulrich Schildhaus; Antonia Dimitrakopoulou-Strauss; Matthias Hm Schwarzbach; Peter Hohenberger
Journal:  World J Surg Oncol       Date:  2008-04-04       Impact factor: 2.754
  5 in total
  1 in total

1.  Clinicopathologic Features and Clinical Outcomes of Esophageal Gastrointestinal Stromal Tumor: Evaluation of a Pooled Case Series.

Authors:  Fan Feng; Yangzi Tian; Zhen Liu; Guanghui Xu; Shushang Liu; Man Guo; Xiao Lian; Daiming Fan; Hongwei Zhang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.